The broad long-term objectives of this grant proposal are to enhance our understanding of blood cell adhesion phenomena and to translate that knowledge into improved diagnosis, treatment and prevention of disease. In previous grant periods, the biology of the beta3 integrin receptors GPIIb/llla (alphaIIbbeta3) and alphaVbeta3 was studied using monoclonal antibodies and analysis of patients with Glanzmann thrombasthenia, including the role of alphaIIbbeta3 in platelet function [which led to the development of monoclonal antibody c7E3 Fab (abciximab) as a new antiplatelet therapy] and the role of the alphaVbeta3 receptor in sickle cell adhesion. In addition, studies in a mouse model of sickle cell disease identified a potential direct role of leukocytes in microvascular obstruction. The recent availability of the crystal structure of alphaVbeta3, in conjunction with the P.l.'s studies on the epitope of 7E3, and advances in computer modeling of protein structure and murine embryonic stem cell biology, open new possibilities for understanding integrin structure and function. Thus, in Specific Aim 1, studies will be performed to: A. Define the 7E3 epitope on alphaIIbbeta3 and alphaVbeta3 using multiple techniques and to assess the alphaIIbbeta3 activation mechanism by studying the binding of 7E3 to receptors locked in various states of activation, B. Engineer the 7E3 epitope into mouse alphabbeta3 and alphaVbeta3 by modifying mouse beta3 and produce a mouse expressing the 7E3 epitope for preclinical studies of new indications for abciximab. C. Use a new computer model of alphaIIb to understand better alphaIIbbeta3 structure and function, and the abnormalities in select patients with Glanzmann thrombasthenia, and D. Express select beta3 Glanzmann thrombasthenia mutations in megakaryocytes derived from murine ES beta3-/- cells for functional analysis.
In Specific Aim 2, important aspects of sickle cell disease will be studied, focusing on the poorly understood biology of large vessel arterial stenosis and thrombosis as well as the potential roles of P-selectin and beta3 integrins in microvascular occlusion and organ damage. These will include: A. The acute and chronic response of """"""""Berkeley"""""""" sickle cell mice and appropriate controls to arterial injury. B. The impact of breeding either P-selectin deficiency or beta3 deficiency into Berkeley sickle cell mice on erythrocyte survival, organ damage, and microvascular occlusion.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL019278-31
Application #
7121100
Study Section
Hematology Subcommittee 2 (HEM)
Program Officer
Ganguly, Pankaj
Project Start
1976-09-01
Project End
2008-08-31
Budget Start
2006-09-01
Budget End
2007-08-31
Support Year
31
Fiscal Year
2006
Total Cost
$619,630
Indirect Cost
Name
Rockefeller University
Department
Biology
Type
Other Domestic Higher Education
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Mancini, Donna; Monteagudo, Juan; Suárez-Fariñas, Mayte et al. (2018) New methodologies to accurately assess circulating active transforming growth factor-?1 levels: implications for evaluating heart failure and the impact of left ventricular assist devices. Transl Res 192:15-29
Zafar, Hina; Shang, Yi; Li, Jihong et al. (2017) ?IIb?3 binding to a fibrinogen fragment lacking the ?-chain dodecapeptide is activation dependent and EDTA inducible. Blood Adv 1:417-428
Wang, Wei; Burg, Nathalie; Vootukuri, Spandana et al. (2016) Increased Smad2/3 phosphorylation in circulating leukocytes and platelet-leukocyte aggregates in a mouse model of aortic valve stenosis: Evidence of systemic activation of platelet-derived TGF-?1 and correlation with cardiac dysfunction. Blood Cells Mol Dis 58:1-5
Coller, Barry S (2015) Blood at 70: its roots in the history of hematology and its birth. Blood 126:2548-60
Coller, B S (2015) ?IIb?3: structure and function. J Thromb Haemost 13 Suppl 1:S17-25
Buitrago, Lorena; Rendon, Augusto; Liang, Yupu et al. (2015) ?IIb?3 variants defined by next-generation sequencing: predicting variants likely to cause Glanzmann thrombasthenia. Proc Natl Acad Sci U S A 112:E1898-907
Jiang, Jian-kang; McCoy, Joshua G; Shen, Min et al. (2014) A novel class of ion displacement ligands as antagonists of the ?IIb?3 receptor that limit conformational reorganization of the receptor. Bioorg Med Chem Lett 24:1148-53
Li, Jihong; Vootukuri, Spandana; Shang, Yi et al. (2014) RUC-4: a novel ?IIb?3 antagonist for prehospital therapy of myocardial infarction. Arterioscler Thromb Vasc Biol 34:2321-9
Provasi, Davide; Negri, Ana; Coller, Barry S et al. (2014) Talin-driven inside-out activation mechanism of platelet ?IIb?3 integrin probed by multimicrosecond, all-atom molecular dynamics simulations. Proteins 82:3231-3240
Wang, Wei; Vootukuri, Spandana; Meyer, Alexander et al. (2014) Association between shear stress and platelet-derived transforming growth factor-?1 release and activation in animal models of aortic valve stenosis. Arterioscler Thromb Vasc Biol 34:1924-32

Showing the most recent 10 out of 70 publications